Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline vs Calcium Gluconate for OHSS Prevention
NCT02875587Phase 2Completed
- Sponsor
- Al Jazeera Hospital
- Start
- Oct 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of calcium gluconate in ovarian hyperstimulation syndrome (OHSS), sponsored by Al Jazeera Hospital. Started Oct 2016; status: completed.
02
Drugs
calcium gluconate
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02875587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875587.